Skip to main content
Premium Trial:

Request an Annual Quote

Migenix Licenses GenomeQuest's Sequence Searcher

NEW YORK (GenomeWeb News) — GenomeQuest said today it is licensing its sequence search technology to Migenix, a Vancouver, BC-based drug developer. 
The company, formerly known as Gene-IT, said Migenix will use its GenomeQuest product in its clinical programs, which include drug candidates for hepatitis C, catheter-related infections, and dermatological diseases.
GenomeQuest said its application is used by biologists evaluating gene sequences and by patent lawyers who are considering issues of patentability of certain sequences.
The technology comprises close to 50 million patented sequences, the company said.
Financial terms of the agreement were not released.
Gene-IT said last week it has changed its name to GenomeQuest.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.